Rimas J. Orentas
Affiliations: | Medical College of Wisconsin, Milwaukee, WI, United States |
Area:
Immunology, Molecular BiologyGoogle:
"Rimas Orentas"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tian M, Wei JS, Shivaprasad N, et al. (2023) Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma. Cell Reports. Medicine. 101212 |
| Masih KE, Gardner RA, Chou HC, et al. (2023) A stem cell epigenome is associated with primary nonresponse to CD19 CAR T-cells in pediatric acute lymphoblastic leukemia. Blood Advances |
| Palani HK, Arunachalam AK, Yasar M, et al. (2022) Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India. Bone Marrow Transplantation |
| Vitanza NA, Wilson AL, Huang W, et al. (2022) Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety. Cancer Discovery |
| Sullivan PM, Kumar R, Li W, et al. (2022) FGFR4-targeted chimeric antigen receptors (CARs) combined with anti-myeloid poly-pharmacy effectively treats orthotopic rhabdomyosarcoma. Molecular Cancer Therapeutics |
| Wang L, Zhang Y, Anderson E, et al. (2022) Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line. Frontiers in Immunology. 13: 825364 |
| Maschan M, Caimi PF, Reese-Koc J, et al. (2021) Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients. Nature Communications. 12: 7200 |
| Brohl AS, Sindiri S, Wei JS, et al. (2021) Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. Cell Reports. 37: 110047 |
| Vitanza NA, Johnson AJ, Wilson AL, et al. (2021) Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis. Nature Medicine |
| Zhang HF, Hughes CS, Li W, et al. (2021) Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma. Cancer Discovery |